产品介绍
爱思益普已建立了400+激酶
我们的优势：
激酶种类多：目前已建成激酶库超过400个并不断扩大，覆盖常用酪氨酸激酶及常见突变激酶；
检测方法：TR-FRET(LANCE Ultra, LathaScreen, HTRF)，荧光法(Kinase-Glo, ADP-Glo)，Z`-LYTE，Binding assay等。
爱思益普已建立的激酶列表
部分验证数据（需要更多验证数据请联系我们）
参考文献：
[1]. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples. Cancer Chemother Pharmacol. 2009 Sep;64(4):723-32.
[2]. Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseases. J Immunol. 2013, 191(7), 3568-3577.
[3].Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia. J Med Chem. 2012 Oct 25;55(20):8721-34.
